Chinese pharmaceutical company Sinovac Biotech Ltd. is ramping up the production of CoronaVac, an inactivated COVID-19 vaccine, to ensure global supply, according to Yin Weidong, chairman and CEO of the company. Sinovac has received vaccine orders from Brazil, Indonesia, Turkey, Chile and other countries and regions, and we are making every effort to expand the production capacity, said Yin in an interview with Xinhua News Agency. We hope the vaccine will protect more people around the world.
The Sinovac vaccine has been approved for emergency use in several countries, including China, Indonesia, Brazil and Chile, according to Yin.
Yin added that the company has constructed a second production line, which will start operation in February, increasing its annual production capacity to 1 billion doses.
Sinovac vaccine shows good efficacy in clinical trials: company chairman southeastasiapost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from southeastasiapost.com Daily Mail and Mail on Sunday newspapers.
China Focus: Sinovac increases vaccine production to ensure global supply: company chairman - China News sina.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com Daily Mail and Mail on Sunday newspapers.
A new Chinese study found that vaccines currently available for mass vaccination in China can effectively neutralize the new coronavirus variant first identified in the UK last month, according to an official in charge of vaccine development under the State Council on Saturday.
Vaccines available in China works against new COVID-19 variant: study cgtn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cgtn.com Daily Mail and Mail on Sunday newspapers.